ML

Investor profile

Melanie Leitner

Venture capital & Chief Scientific Officer at ALS Investment Fund

Melanie Leitner is a Chief Scientific Officer at ALS Investment Fund, whose known portfolio counts 9 companies.

Is Melanie Leitner a fit for your startup?

Paste your website. AI checks the fit and scores every other investor too.

Investment focus

Focus
ALSBiotechDrug DiscoveryGenomicsNeurodegenerationPharma

Contacts

mle***@***.comPhone number on fileLinkedIn profile on fileAvailable after registration.
Get contact

Affiliated funds' portfolios

Chief Scientific Officer at ALS Investment Fund, whose known portfolio counts 9 companies

  • QurAlis
  • Verge Genomics
  • Amylyx Pharmaceuticals
  • Emulate
  • Prilenia
  • Orphazyme
  • Apic Bio
  • Bloom Science
  • VectorY

Investor Profile

Melanie Leitner is listed against sector Healthcare, and focus areas ALS, Biotech, Drug Discovery and Genomics in the database.

Stage-wise, the deals at ALS Investment Fund cluster around Growth, Seed and Series A rounds.

What the affiliated firm has backed is the closest available signal on whether Melanie Leitner is worth approaching.

Colleagues at ALS Investment Fund

Frequently asked questions

Who is Melanie Leitner?

Melanie Leitner is a venture capital investor based in Boston, Massachusetts, United States, listed as Chief Scientific Officer at ALS Investment Fund. The known portfolio of that firm counts 9 companies. That portfolio belongs to the firm, not to Melanie Leitner personally.

What does Melanie Leitner invest in?

Listed sectors include Healthcare; listed focus areas include ALS, Biotech, Drug Discovery and Genomics. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.

What stage does Melanie Leitner invest at?

ALS Investment Fund appears in Growth, Seed and Series A rounds across its known deals, and Melanie Leitner is listed there as Chief Scientific Officer. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.

Which firm is Melanie Leitner listed at?

Melanie Leitner is listed as Chief Scientific Officer at ALS Investment Fund. 2 other people in the database share a firm with Melanie Leitner.

How do I contact Melanie Leitner?

An email address, a phone number and a LinkedIn page are on file for Melanie Leitner. The address stays masked on this page and is readable inside RaiseHunt after you create an account.

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal